IQE Explores Sale of Its Taiwanese Subsidiary in Strategic Move

IQE, a prominent UK-based company specializing in epitaxial wafers and substrates, has recently shared insights into the market landscape. According to their latest updates, the market’s recovery trajectory has not met expectations. Consequently, IQE anticipates that its revenue for 2024 will remain unchanged from the previous year, reflecting a stagnant growth phase.

In light of these market conditions, the company has embarked on a strategic review to explore potential paths forward. This review could play a pivotal role in shaping IQE’s approach to navigating the current economic climate, ensuring they remain agile and adaptive.

As the semiconductor industry continues to oscillate, IQE is poised to evaluate all options in this strategic review process. This move highlights their commitment to resilience and their proactive stance in addressing unforeseen market challenges.